Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00385541 · ClinicalTrials.gov registry record · Phase 4
Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA)
A Phase 4 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00385541 is a Phase 4 study that has completed, run by Columbia University. The registered enrollment target is 50 participants.
The verdict
NCT00385541, a Phase 4 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
Both morphine and hydromorphone are pain medications commonly used after surgery. It is thought at the institution that hydromorphone causes less side effects but this has not been studied. The study proposes to treat the patients with either morphine or hydromorphone and determine how much nausea, vomiting, and itching they have with each drug
Interventions
- DRUG Hydromorphone PCA
- DRUG Morphine PCA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2003-11 |
| Est. Completion | 2007-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00385541
The ClinicalTrials.gov registry entry for NCT00385541 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydromorphone PCA is the first listed.
NCT00385541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00385541 about?
NCT00385541 is a clinical study titled "Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA)". Both morphine and hydromorphone are pain medications commonly used after surgery. It is thought at the institution that hydromorphone causes less side effects but this has not been studied. The study proposes to treat the patients with either morphine or hydromorphone and determine how much nausea, ...
What is the current status of trial NCT00385541?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2003-11. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00385541?
The interventions under investigation include: Hydromorphone PCA (DRUG), Morphine PCA (DRUG).
Who is sponsoring clinical trial NCT00385541?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.